A case study of a pharmaceutical client who supplemented in-house capacity with Culture's...
November 24
.png?width=300&name=5c60b512d885ee45dad12d32_CultureLogo%20(1).png "Culture")
A case study of a pharmaceutical client who supplemented in-house capacity with Culture's...
As we launch our 5L bioreactors, our co-founder and CEO Will Patrick reflects on why this is such a...
revised December 15, 2022
How empowering cell line engineering groups with Culture's cloud...
Diana Eng is the director of Culture’s Bioprocess Alliance Management (BAM) team where she...
.png)
The recent increase in consumer demand for sustainably made products has led to a surge in the...
Get to know Collin Edington, Hardware Engineering Manager at Culture and our first employee. Collin...
While you may be aware that synthetic biology is on the rise, you may not know that there’s a major...
Many of Culture’s clients have questions pertaining to the right time to transition to bioreactors...
Scaling up a bioprocess can be challenging, but thorough preparation for scale-up early in the...
revised December 16, 2022
In addition to the multitude of different biological pathways and ...
